WP
Woodline Partners Portfolio holdings
AUM
$18.9B
1-Year Return
23.37%
This Quarter Return
-1.08%
1 Year Return
+23.37%
3 Year Return
+125.78%
5 Year Return
+185.63%
10 Year Return
–
AUM
$8.53B
AUM Growth
+$112M
(+1.3%)
Cap. Flow
+$339M
Cap. Flow
% of AUM
3.98%
Top 10 Holdings %
Top 10 Hldgs %
16.9%
Holding
809
New
193
Increased
196
Reduced
149
Closed
229
Top Buys
| 1 |
Analog Devices
ADI
|
$178M |
| 2 |
AbbVie
ABBV
|
$123M |
| 3 |
Electronic Arts
EA
|
$107M |
| 4 |
Autodesk
ADSK
|
$95.8M |
| 5 |
Keysight
KEYS
|
$82.3M |
Top Sells
| 1 |
HES
Hess
HES
|
$125M |
| 2 |
Amphenol
APH
|
$111M |
| 3 |
Cencora
COR
|
$106M |
| 4 |
Microsoft
MSFT
|
$99.2M |
| 5 |
Neurocrine Biosciences
NBIX
|
$95.5M |
Sector Composition
| 1 | Healthcare | 38.53% |
| 2 | Technology | 26.19% |
| 3 | Industrials | 9.44% |
| 4 | Energy | 7.95% |
| 5 | Consumer Discretionary | 5.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
A.O. Smith
AOS
$10.3B
| $7.61M | 0.09% |
115,028
+86,446
| +302% | +$5.72M |
|
252
Pliant Therapeutics
PLRX
$114M
| $7.56M | 0.09% |
436,252
+178,754
| +69% | +$3.1M |
|
253
Phreesia
PHR
$1.67B
| $7.36M | 0.09% |
+394,082
| New | +$7.36M |
|
254
Endava
DAVA
$553M
| $7.34M | 0.09% |
127,931
+51,871
| +68% | +$2.97M |
|
255
Ultragenyx Pharmaceutical
RARE
$3.07B
| $7.33M | 0.09% |
205,483
-31,081
| -13% | -$1.11M |
|
256
Workiva
WK
$4.48B
| $7.23M | 0.08% |
71,384
-91,091
| -56% | -$9.23M |
|
257
TE Connectivity
TEL
$61.7B
| $7.2M | 0.08% |
+58,324
| New | +$7.2M |
|
258
Granite Ridge Resources
GRNT
$700M
| $7.2M | 0.08% |
+1,180,176
| New | +$7.2M |
|
259
Antero Resources
AR
$10.1B
| $7.15M | 0.08% |
281,861
-606,853
| -68% | -$15.4M |
|
260
Ventyx Biosciences
VTYX
$180M
| $7.08M | 0.08% |
203,783
+53,783
| +36% | +$1.87M |
|
261
Wave Life Sciences
WVE
$1.32B
| $7.06M | 0.08% |
+1,228,683
| New | +$7.06M |
|
262
Qiagen
QGEN
$10.3B
| $6.99M | 0.08% |
162,714
+85,030
| +109% | +$3.65M |
|
263
Flowserve
FLS
$7.22B
| $6.96M | 0.08% |
+175,117
| New | +$6.96M |
|
264
Vita Coco
COCO
$2.19B
| $6.95M | 0.08% |
266,749
+116,747
| +78% | +$3.04M |
|
265
Leggett & Platt
LEG
$1.35B
| $6.94M | 0.08% |
273,102
+80,376
| +42% | +$2.04M |
|
|
VERV
266
DELISTED
Verve Therapeutics
VERV
| $6.91M | 0.08% |
521,260
+126,839
| +32% | +$1.68M |
|
|
NVRO
267
DELISTED
NEVRO CORP.
NVRO
| $6.85M | 0.08% |
356,285
+183,807
| +107% | +$3.53M |
|
268
Baidu
BIDU
$35.1B
| $6.83M | 0.08% |
+50,843
| New | +$6.83M |
|
269
Ambarella
AMBA
$3.54B
| $6.8M | 0.08% |
+128,309
| New | +$6.8M |
|
270
Allegro MicroSystems
ALGM
$5.66B
| $6.73M | 0.08% |
+210,719
| New | +$6.73M |
|
271
Legend Biotech
LEGN
$6.66B
| $6.72M | 0.08% |
100,000
-69,305
| -41% | -$4.66M |
|
272
PMV Pharmaceuticals
PMVP
$77.4M
| $6.7M | 0.08% |
1,090,740
+357,005
| +49% | +$2.19M |
|
273
Comstock Resources
CRK
$4.66B
| $6.69M | 0.08% |
606,855
-2,017,550
| -77% | -$22.3M |
|
274
Apogee Therapeutics
APGE
$2.26B
| $6.6M | 0.08% |
+310,000
| New | +$6.6M |
|
275
Waste Connections
WCN
$46.1B
| $6.55M | 0.08% |
48,797
-60,004
| -55% | -$8.06M |
|